WO2000071679A3 - Proteines d'oxydoreductase - Google Patents

Proteines d'oxydoreductase Download PDF

Info

Publication number
WO2000071679A3
WO2000071679A3 PCT/US2000/013879 US0013879W WO0071679A3 WO 2000071679 A3 WO2000071679 A3 WO 2000071679A3 US 0013879 W US0013879 W US 0013879W WO 0071679 A3 WO0071679 A3 WO 0071679A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxrd
oxidoreductase proteins
human oxidoreductase
provides
proteins
Prior art date
Application number
PCT/US2000/013879
Other languages
English (en)
Other versions
WO2000071679A2 (fr
Inventor
Henry Yue
Y Tom Tang
Mariah R Baughn
Dyung Aina M Lu
Original Assignee
Incyte Genomics Inc
Henry Yue
Y Tom Tang
Mariah R Baughn
Dyung Aina M Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Henry Yue, Y Tom Tang, Mariah R Baughn, Dyung Aina M Lu filed Critical Incyte Genomics Inc
Priority to JP2000620057A priority Critical patent/JP2003517288A/ja
Priority to AU50342/00A priority patent/AU5034200A/en
Priority to EP00932647A priority patent/EP1183370A2/fr
Priority to CA002374413A priority patent/CA2374413A1/fr
Publication of WO2000071679A2 publication Critical patent/WO2000071679A2/fr
Publication of WO2000071679A3 publication Critical patent/WO2000071679A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

L'invention concerne des protéines d'oxydoréductase humaines et des polynucléotides identifiant et codant pour ces protéines d'oxydoréductase humaines. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne en outre des méthodes permettant de diagnostiquer, de traiter ou de prévenir des troubles associés à l'expression des protéines d'oxydoréductase humaines.
PCT/US2000/013879 1999-05-20 2000-05-19 Proteines d'oxydoreductase WO2000071679A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000620057A JP2003517288A (ja) 1999-05-20 2000-05-19 オキシドレダクターゼタンパク質
AU50342/00A AU5034200A (en) 1999-05-20 2000-05-19 Oxidoreductase proteins
EP00932647A EP1183370A2 (fr) 1999-05-20 2000-05-19 Proteines d'oxydoreductase
CA002374413A CA2374413A1 (fr) 1999-05-20 2000-05-19 Proteines d'oxydoreductase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13504999P 1999-05-20 1999-05-20
US60/135,049 1999-05-20
US13674099P 1999-05-27 1999-05-27
US60/136,740 1999-05-27

Publications (2)

Publication Number Publication Date
WO2000071679A2 WO2000071679A2 (fr) 2000-11-30
WO2000071679A3 true WO2000071679A3 (fr) 2001-07-05

Family

ID=26832934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/013879 WO2000071679A2 (fr) 1999-05-20 2000-05-19 Proteines d'oxydoreductase

Country Status (5)

Country Link
EP (1) EP1183370A2 (fr)
JP (1) JP2003517288A (fr)
AU (1) AU5034200A (fr)
CA (1) CA2374413A1 (fr)
WO (1) WO2000071679A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034783A1 (en) * 2000-04-18 2002-03-21 Rachel Meyers 39228, a novel human alcohol dehydrogenase and uses therefor
US20020001807A1 (en) * 2000-03-31 2002-01-03 Meyers Rachel A. 21509 and 33770, novel human dehydrogenase family members and uses thereof
EP1331227A1 (fr) * 2002-01-24 2003-07-30 Millennium Pharmaceuticals, Inc. 62113, un membre de la famille des Acyl-CoA dehydrogenases et ses utilisations
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996008568A2 (fr) * 1994-09-12 1996-03-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Clonage et expression d'adn complementaire codant pour la dihydropyrimidine deshydrogenase humaine
WO1998020137A1 (fr) * 1996-11-07 1998-05-14 Inctye Pharmaceuticals, Inc. Squalene epoxydase humaine
WO1998045435A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. MARQUEURS SECRETES DE SEQUENCE EXPRIMEE (sEST)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996008568A2 (fr) * 1994-09-12 1996-03-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Clonage et expression d'adn complementaire codant pour la dihydropyrimidine deshydrogenase humaine
WO1998020137A1 (fr) * 1996-11-07 1998-05-14 Inctye Pharmaceuticals, Inc. Squalene epoxydase humaine
WO1998045435A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. MARQUEURS SECRETES DE SEQUENCE EXPRIMEE (sEST)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EMBL database, Heidelberg, FRG Emest_Hum20 accession number AA376285 18 April 1997 ADAMS, M.D. ET AL.: "EST88740 HSC172 cells II Homo sapiens cDNA 5' end similar to male sterility 2" *
EMBL database, Heidelberg, FRG Emhtg accession number AC013828 16 November 1999 BIRREN, B. ET AL.: "Homo sapiens clone RP11-23B7, WORKING DRAFT SEQUENCE, 20 unordered pieces" *

Also Published As

Publication number Publication date
CA2374413A1 (fr) 2000-11-30
JP2003517288A (ja) 2003-05-27
WO2000071679A2 (fr) 2000-11-30
EP1183370A2 (fr) 2002-03-06
AU5034200A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
WO2001012662A3 (fr) Proteines associees a la membrane
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2000015793A3 (fr) Proteines gpcr humaines
WO2000034477A3 (fr) Proteines associees a des neurones
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000009709A3 (fr) Proteases et proteines associees
WO2000026245A3 (fr) Proteines de transport membranaire
WO2000012703A3 (fr) Molecules associees au transport de proteines
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2001007612A3 (fr) Recepteurs et proteines associees
WO2000052151A3 (fr) Proteines de secretion humaines
WO2000078953A3 (fr) Proteines de transport humaines
WO2000014251A3 (fr) Transferases humaines
WO2000044900A3 (fr) Proteines liant des acides nucleiques
WO2000056891A3 (fr) Proteines transmembranaires humaines
WO2001044448A3 (fr) Proteines d'oxydoreductase humaines
WO2000020604A3 (fr) Molecules d'oxydoreductase
WO2000042201A3 (fr) Peptidases humaines
WO2000028045A3 (fr) Hydrolases humaines
WO2000065054A3 (fr) Proteines humaines associees aux membranes
WO2000078954A3 (fr) Proteines de regulateur de transcription humaines
WO2000008155A3 (fr) Proteines associees a un recepteur humain
WO2000001821A3 (fr) Proteines associees a la neurotransmission
WO2000060082A3 (fr) Proteines associees a une vesicule

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2374413

Country of ref document: CA

Ref country code: JP

Ref document number: 2000 620057

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: CA

Ref document number: 2374413

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09979299

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2000932647

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000932647

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000932647

Country of ref document: EP